These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3033469

  • 21. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
    Orosz F, Telegdi M, Liliom K, Solti M, Korbonits D, Ovádi J.
    Mol Pharmacol; 1990 Dec; 38(6):910-6. PubMed ID: 2147457
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B, Ruckstuhl M, Landry Y.
    J Pharmacol; 1982 Dec; 13(2):307-16. PubMed ID: 6285085
    [Abstract] [Full Text] [Related]

  • 27. CAPP-calmodulin: a potent competitive inhibitor of calmodulin actions.
    Newton DL, Klee CB.
    FEBS Lett; 1984 Jan 09; 165(2):269-72. PubMed ID: 6319184
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells.
    Glass-Marmor L, Morgenstern H, Beitner R.
    Eur J Pharmacol; 1996 Oct 17; 313(3):265-71. PubMed ID: 8911923
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.
    Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, Grover GJ.
    J Cardiovasc Pharmacol; 1992 Aug 17; 20(2):251-60. PubMed ID: 1381016
    [Abstract] [Full Text] [Related]

  • 32. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA, Moy GM, Fang B, Solomon SS.
    Arch Biochem Biophys; 1995 Nov 10; 323(2):223-32. PubMed ID: 7487081
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interaction of calmodulin with iodothyronines: effect of iodothyronines on the calmodulin activation of cyclic AMP phosphodiesterase.
    Rao GS, Lemoch H, Cronrath C.
    Mol Cell Endocrinol; 1987 Sep 10; 53(1-2):45-52. PubMed ID: 2822507
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ca(2+)-ionophore A23187 and the Ca(2+)-mobilizing hormones serotonin, vasopressin, and bradykinin increase mitochondrially bound hexokinase in muscle.
    Bassukevitz Y, Chen-Zion M, Beitner R.
    Biochem Med Metab Biol; 1992 Apr 10; 47(2):181-8. PubMed ID: 1515175
    [Abstract] [Full Text] [Related]

  • 38. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin.
    Williams JP, McKenna MA, Thames AM, McDonald JM.
    Biochem Cell Biol; 2000 Apr 10; 78(6):715-23. PubMed ID: 11206583
    [Abstract] [Full Text] [Related]

  • 39. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 40. Polymyxin B is a selective and potent antagonist of calmodulin.
    Hegemann L, van Rooijen LA, Traber J, Schmidt BH.
    Eur J Pharmacol; 1991 May 25; 207(1):17-22. PubMed ID: 1915592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.